West Pharmaceutical Services Overview

  • Year Founded
  • 1923

Year Founded

  • Status
  • Public

  • Employees
  • 10,800

Employees

  • Stock Symbol
  • WST

Stock Symbol

  • Investments
  • 14

  • Share Price
  • $416.42
  • (As of Friday Closing)

West Pharmaceutical Services General Information

Description

West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 530 Herman O. West Drive
  • Exton, PA 19341-1147
  • United States
+1 (610)
Primary Industry
Medical Supplies
Stock Exchange
NYS
Corporate Office
  • 530 Herman O. West Drive
  • Exton, PA 19341-1147
  • United States
+1 (610)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

West Pharmaceutical Services Stock Performance

As of 13-Nov-2026, West Pharmaceutical Services’s stock price is $416.42. Its current market cap is $29B with 69.7M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$416.42 $411.30 $223.83 - $438.27 $29B 69.7M 602K $8.96

West Pharmaceutical Services Financials Summary

As of 30-Sep-2026, West Pharmaceutical Services has a trailing 12-month revenue of $3.4B.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 25,968,818 19,463,610 23,536,565 25,461,443
Revenue 3,396,700 3,074,100 2,893,200 2,949,800
EBITDA 963,500 755,300 724,300 816,300
Net Income 638,900 493,700 492,700 593,400
Total Assets 4,060,700 4,270,000 3,643,400 3,829,500
Total Debt 305,000 321,100 302,300 309,000
Public Fundamental Data provided by Morningstar, Inc. disclaimer

West Pharmaceutical Services Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore West Pharmaceutical Services‘s full profile, request access.

Request a free trial

West Pharmaceutical Services Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnolog
Medical Supplies
Exton, PA
10,800 As of 2025

Osaka, Japan
 

Franklin Lakes, NJ
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

West Pharmaceutical Services Competitors (6)

One of West Pharmaceutical Services’s 6 competitors is Nipro, a Corporation company based in Osaka, Japan.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Nipro Corporation Osaka, Japan
Becton, Dickinson and Company Corporation Franklin Lakes, NJ
GE HealthCare Technologies Corporation Chicago, IL
Baxter India Corporation Gurgaon, India
SteriPack Group Private Equity-Backed Bristol, United Kingdom
To view West Pharmaceutical Services’s complete competitors history, request access »

West Pharmaceutical Services Patents

West Pharmaceutical Services Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026212943-A1 Twistable closure systems, container systems, and methods for aseptic medicament filling Pending 29-Mar-2025
WO-2026198409-A1 Medicament container systems with a plug and associated methods for aseptic medicament filling Pending 17-Mar-2025
WO-2026188157-A1 Electively open lumen conduit system and methods for preventing contamination Pending 07-Mar-2025
US-20260102281-A1 Needle injection system with backpressure sensing Pending 10-Oct-2024
WO-2026080584-A1 Needle injection system with backpressure sensing Pending 10-Oct-2024 A61F9/0017
To view West Pharmaceutical Services’s complete patent history, request access »

West Pharmaceutical Services Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

West Pharmaceutical Services Investments & Acquisitions (14)

West Pharmaceutical Services’s most recent deal was a Later Stage VC with NanoPass Technologies for . The deal was made on 15-Jul-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
NanoPass Technologies 15-Jul-2024 Later Stage VC Drug Delivery
Pharma Latch 11-Aug-2022 Later Stage VC Medical Supplies
AcousticaBio 01-Feb-2022 Early Stage VC Drug Delivery
Adaptive3D 29-Sep-2020 Later Stage VC Other Commercial Products
Daikyo Seiko 16-Oct-2019 Corporate Medical Supplies
You’re viewing 5 of 14 investments and acquisitions. Get the full list »

West Pharmaceutical Services ESG

Risk Overview

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Healthcare

Industry

Rank

Percentile

Medical Supplies

Subindustry

Rank

Percentile

To view West Pharmaceutical Services’s complete esg history, request access »

West Pharmaceutical Services Exits (1)

West Pharmaceutical Services’s most recent exit was on 29-Sep-2020 from Adaptive3D. The exit was categorized as with 7 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Adaptive3D 29-Sep-2020 Completed
  • 7 buyers
To view West Pharmaceutical Services’s complete exits history, request access »

West Pharmaceutical Services Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
West Pharmaceutical Services Of Florida Saint Petersburg, FL 1993
Tech Group Grand Rapids Walker, MI 1984

West Pharmaceutical Services FAQs

  • When was West Pharmaceutical Services founded?

    West Pharmaceutical Services was founded in 1923.

  • Where is West Pharmaceutical Services headquartered?

    West Pharmaceutical Services is headquartered in Exton, PA.

  • What is the size of West Pharmaceutical Services?

    West Pharmaceutical Services has 10,800 total employees.

  • What industry is West Pharmaceutical Services in?

    West Pharmaceutical Services’s primary industry is Medical Supplies.

  • Is West Pharmaceutical Services a private or public company?

    West Pharmaceutical Services is a Public company.

  • What is West Pharmaceutical Services’s stock symbol?

    The ticker symbol for West Pharmaceutical Services is WST.

  • What is the current stock price of West Pharmaceutical Services?

    As of 13-Nov-2026 the stock price of West Pharmaceutical Services is $416.42.

  • What is the current market cap of West Pharmaceutical Services?

    The current market capitalization of West Pharmaceutical Services is $29B.

  • What is West Pharmaceutical Services’s current revenue?

    The trailing twelve month revenue for West Pharmaceutical Services is $3.4B.

  • Who are West Pharmaceutical Services’s competitors?

    Nipro, Becton, Dickinson and Company, GE HealthCare Technologies, Baxter India, and SteriPack Group are some of the 6 competitors of West Pharmaceutical Services.

  • What is West Pharmaceutical Services’s annual earnings per share (EPS)?

    West Pharmaceutical Services’s EPS for 12 months was $8.96.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process